Nuclear receptor corepressor (NCoR) is a positive prognosticator for cervical cancer

Arch Gynecol Obstet. 2021 Nov;304(5):1307-1314. doi: 10.1007/s00404-021-06053-3. Epub 2021 Apr 16.

Abstract

Purpose: Enzymes with epigenetic functions play an essential part in development of cancer. However, the significance of epigenetic changes in cervical carcinoma as a prognostic factor has not been fully investigated. Nuclear receptor corepressor (NCoR) presents itself as a potentially important element for epigenetic modification and as a potential prognostic aspect in cervical cancer.

Methods: By immunohistochemical staining of 250 tumor samples, the expression strength of NCoR was measured and evaluated by immunoreactive score (IRS) in the nucleus and cytoplasm.

Results: A low expression of NCoR in our patients was a disadvantage in overall survival. Expression of NCoR was negatively correlated with viral oncoprotein E6, acetylated histone H3 acetyl K9 and FIGO status, and positively correlated to p53.

Conclusions: Our study has identified epigenetic modification of tumor cells thus seems to be of relevance in cervical cancer as well for diagnosis, as a marker or as a potential therapeutic target in patients with advanced cervical carcinoma.

Keywords: Cervical cancer; Epigenetic; Immunohistochemistry; NCoR; Prognosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Co-Repressor Proteins
  • Epigenesis, Genetic
  • Female
  • Humans
  • Oncogene Proteins, Viral*
  • Prognosis
  • Uterine Cervical Neoplasms* / genetics

Substances

  • Co-Repressor Proteins
  • Oncogene Proteins, Viral